ResearcherCedars-Sinai Medical CenterActive in the last 2 years

Wei Jie Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0435-7261; OpenAlex author ID A5042814066. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2024: 1 paper

Papers 1

Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. Co-author DOI 10.1016/j.freeradbiomed.2024.01.003 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tao Liu · 1 shared paper, 2024 · strength 0.21
- Paper Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.freeradbiomed.2024.01.003 ↗
Qiang Wang · 1 shared paper, 2024 · strength 0.21
- Paper Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.freeradbiomed.2024.01.003 ↗
Omer Hany Miligy Elmadbouh · 1 shared paper, 2024 · strength 0.21
- Paper Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.freeradbiomed.2024.01.003 ↗
Raul A. Urrutia · 1 shared paper, 2024 · strength 0.21
- Paper Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.freeradbiomed.2024.01.003 ↗
Stephen Jacob Pandol · 1 shared paper, 2024 · strength 0.21
- Paper Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.freeradbiomed.2024.01.003 ↗
Arsen Osipov · 1 shared paper, 2024 · strength 0.21
- Paper Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.freeradbiomed.2024.01.003 ↗
Mouad Edderkaoui · 1 shared paper, 2024 · strength 0.21
- Paper Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.freeradbiomed.2024.01.003 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.